Market News & Trends
Crown Bioscience Strengthens Immuno-Oncology Capabilities With HuGEMM
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International (TWSE: ticker 6554), a global drug discovery and development services company providing translational platforms to…
Rexahn Pharmaceuticals Announces Initiation of Phase Ib/IIa Clinical Trial of Novel Oral Anti-Cancer Therapeutic
Rexahn Pharmaceuticals, Inc. recently announced that is has enrolled the first patient in its Phase Ib/IIa clinical trial of a the novel oral anti-cancer agent,…
Advaxis Combination Trial With MedImmune Completes First Dose-Escalation Cohort
Advaxis, Inc. recently announced its combination study with MedImmune, the global biologics research and development arm of AstraZeneca, has completed the first dose-escalation cohort in…
Brammer Biopharmaceuticals & Florida Biologix Merge, Creating Leading CDMO
Brammer Biopharmaceuticals recently announced its merger with Florida Biologix to create the best-in-class cell and gene therapy biologics contract development and manufacturing organization (CDMO). The…
Actinium Receives Orphan Drug Designation From FDA
Actinium Pharmaceuticals, Inc. recently announced that the US Food and Drug Administration (FDA) has granted orphan drug designation for Iomab-B, a radioimmunotherapeutic that conditions relapsed…
MilliporeSigma's CRISPR Epigenetic Activator Named on Top 10 Innovation List
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada, recently announced that The Scientist magazine…
SGS & DiscoverX Enter Collaboration Agreement
SGS has entered into a collaboration with DiscoverX to work together to provide simple and qualified assays for functional comparability, for use in quality control…
Exclusive: Capsugel Prepares to Explore Sale or IPO
By: Carl O’Donnell & Greg Roumeliotis Capsugel, a U.S. maker of capsule products and other drug delivery systems, is preparing to explore a sale or…
Aduro Biotech Announces First Patient Dosed in Combination Clinical Trial
Aduro Biotech, Inc. recently announced that the first patient has been dosed in SEASCAPE, the Phase I/II clinical study designed to evaluate the safety, tolerability…
Quantum Genomics Raises Millions in US & Europe
Quantum Genomics recently announced it has completed a private placement with US institutional investors totalling €5.54 million. Directly following the US capital increase, the company…
Placon Therapeutics Announces Company Launch and FDA Acceptance of IND
Placon Therapeutics recently announced its launch as an independent company and provided an update on its lead product candidate, BTP-114, for which the US FDA…
NDA Group & PharmApprove Announce Merger
NDA Group and PharmApprove recently announced their merger. The newly combined company will allow clients to streamline the global development and commercialization process, accelerating patient…
Genisphere Enters Collaborative Nanotherapeutics Research Agreement
Genisphere LLC has signed a collaborative research agreement with the University of Pennsylvania to study targeted nanotherapeutics in cancer treatment. The collaboration between Genisphere LLC,…
Daiichi Sankyo & ArQule Announce Continuation of Phase III Study
ArQule, Inc. and Daiichi Sankyo recently announced that the independent data monitoring committee (DMC) of the METIV-HCC study conducted the planned interim assessment, and it…
Ajinomoto Althea Expands Capacity of Fill Finish Manufacturing
Ajinomoto Althea, Inc. recently announced it is expanding the capacity of its Fill and Finish operations through the addition of a second manufacturing shift. Althea's…
Ascendia Pharma Announces New Contract Manufacturing Capability to Deliver cGMP Phase I Clinical Trial Materials
Ascendia now offers cGMP manufacturing capabilities for both oral and parenteral dosage forms to support your Phase I clinical trials. We have recently finished the qualification…
Patheon Signs Flexible Manufacturing Agreement With Amgen
Patheon, the leading global provider of pharmaceutical development and manufacturing services, recently announced it has signed a manufacturing agreement with Amgen, one of the world’s…
Inovio Pharmaceuticals Acquires Needle-Free Injection Technology to Advance Strategy for Next-Generation Vaccines
Inovio Pharmaceuticals, Inc. recently announced it has signed a definitive agreement to acquire all of Bioject Medical Technologies Inc.’s assets, including pioneering needle-free jet injection…
CordenPharma Announces Expanded Aseptic & Oral Development Capabilities
As part of a long term strategy to meet increasing customer demands, CordenPharma has completed two additional key investments to strengthen its development and manufacturing…
Chiasma Initiates Second Phase III Trial of Octreotide Capsules
Chiasma, Inc. recently announced the initiation of a second Phase III clinical trial to investigate the non-inferiority of octreotide capsules to once-a-month injectable somatostatin analogs.…
